Now showing items 1-1 of 1
Solid malignancies among patients in the Wegener's granulomatosis etanercept trial
(Wiley Subscription Services, Inc., A Wiley Company, 2006-05)
Objective Etanercept is a soluble fusion protein designed to inhibit tumor necrosis factor (TNF). During the Wegener's Granulomatosis Etanercept Trial (WGET), a placebo-controlled trial of etanercept given in addition to ...